Top compounds associated with response to CCDC17


Feature Type Standardized
Nominal ANOVA
mRNA palmostatin B CTRPv2 pan-cancer AAC -0.08 0.07
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.053 0.07
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.08
mRNA temsirolimus CTRPv2 pan-cancer AAC 0.085 0.08
mRNA Nilotinib GDSC1000 pan-cancer AAC -0.067 0.08
mRNA Zibotentan GDSC1000 pan-cancer AAC -0.061 0.08
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.062 0.08
mRNA FSC231 CTRPv2 pan-cancer AAC -0.13 0.08
mRNA KIN001-270 GDSC1000 pan-cancer AAC 0.06 0.08
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.08
Download CSV